Oxford BioMedica Company

Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Technology: AgeTech Companies, CAR-T therapy
Industry: Healthcare, Public
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 1995-01-01
Employees Number: 501-1000
Funding Status: M&A
Investors Number: 3
Total Funding: 62300000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-09-22
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership